Prognostic Evaluation Using Nutrition-Inflammation Biomarkers from Routine Blood Tests in Metastatic Breast Cancer: A Boruta Algorithm-Optimized Feature Selection Study - Top-Institutions - MDSpire

Prognostic Evaluation Using Nutrition-Inflammation Biomarkers from Routine Blood Tests in Metastatic Breast Cancer: A Boruta Algorithm-Optimized Feature Selection Study

  • By

  • Nong, Wen-xiong

  • Huang, Sheng-kai

  • Zhang, Wenhai

  • Tan, Yang

  • Wu, Zhi-dong

  • Liang, Wan-wang

  • Wu, Rui-zheng

  • May 13, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Institut Curie
    Institut Curie

    Paris, Île-de-France

    Key Differentiators

    • Oncology

  • #3

    Swedish Cancer Institute
    Swedish Cancer Institute

    Seattle, Washington

    Key Differentiators

    • Oncology

  • #4

    Duke University Medical Center
    Duke University Medical Center

    Durham, North Carolina

    Key Differentiators

    • Oncology

Original Source(s)

Prognostic Evaluation Using Nutrition-Inflammation Biomarkers from Routine Blood Tests in Metastatic Breast Cancer: A Boruta Algorithm-Optimized Feature Selection Study

  • by Nong, Wen-xiong , Huang, Sheng-kai , Zhang, Wenhai , Tan, Yang , Wu, Zhi-dong , Liang, Wan-wang , Wu, Rui-zheng

  • May 13, 2026

Related Content

Ultra-high-sensitivity next-generation sequencing–based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort

Predicting preoperative axillary lymph node metastasis to guide surgical decisions in invasive breast cancer

Stimuli-responsive nanoplatforms for sonodynamic immunotherapy: opportunities and challenges in cancer treatment